Efectos Adversos
Leukemia secondary to oncology chemotherapy
23-01-2020 Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify
A disorder characterized by leukemia arising as a result of the mutagenic effect of chemotherapy agents.
Myelodysplastic syndrome
23-01-2020 Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify
A disorder characterized by insufficiently healthy hematapoietic cell production by the bone marrow.
Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify
23-01-2020 Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify
-
Skin papilloma
23-01-2020 Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify
A disorder characterized by the presence of one or more warts.
Treatment related secondary malignancy
23-01-2020 Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify
A disorder characterized by development of a malignancy most probably as a result of treatment for a previously existing malignancy.
Tumor hemorrhage
23-01-2020 Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify
A disorder characterized by bleeding in a tumor.
Tumor pain
23-01-2020 Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify
A disorder characterized by a sensation of marked discomfort from a neoplasm that may be pressing on a nerve, blocking blood vessels, inflamed or fractured from metastasis.
